Drug Type Small molecule drug |
Synonyms BG45 |
Target |
Action inhibitors |
Mechanism HDAC3 inhibitors(Histone deacetylase 3 inhibitors), Epigenetic drug |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC11H10N4O |
InChIKeyLMWPVSNHKACEKW-UHFFFAOYSA-N |
CAS Registry926259-99-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Myeloma | Preclinical | United States | 05 Aug 2013 |